Medartis 2025 full year results presentation

Medartis Holding AG / CH0386200239

Medartis Holding AG / Key word(s): Annual Results


10.02.2026 / 10:00 CET/CEST

---

INVITATION ? PRESS- AND INVESTOR CONFERENCE

We are pleased to invite you to the presentation of our 2025 annual results and 2026 outlook on Tuesday, 17 March 2026 in Basel. We will publish the following documents on our corporate website and distribute them to our newsletter subscribers before 07:00 am.   (a)  Press Release (b)  Integrated Annual Report 2025 (c)  Conference Presentation   If you would like to subscribe to our mailing list, please use the following online form. The event will be held in English.    

Date:	Tuesday, 17th March 2026
Time (Swiss time):	10:30 - 11:30
Venue:	Medartis HQ at Hochbergerstrasse 60E, Basel
Speakers:	Matthias Schupp, CEO Peter Hackel, CFO (new)

    Registration for the event ON SITE: If you would like to attend the event in person, please send an email to [e-mail].   VIDEO WEBCAST WITH Q&A SECTION: The conference will take place on site in Basel and will also be broadcast via MS Teams. Webcast participants can submit their questions by raising the hand symbol or in writing via chat. To participate via smartphone, you need to install the Microsoft Teams app. Please dial in 5 minutes before the conference begins to complete the registration process quickly.   TO REGISTER for the online webcast, click here: >> https://medartis.com/en/results-conference A recording of this event will be available shortly afterwards via the same link, as well as on our website.   We look forward to your participation in the conference.   Kind regards   Medartis Corporate Communications        

Phone / switchboard:	[phone] / [phone]
Email (journalists):	[e-mail]
Email (investors):	[e-mail]
Homepage:	www.medartis.com

         

About Medartis
Founded in 1997 and headquartered in Basel, Switzerland, the Medartis Group is one of the world's leading manufacturers and providers of medical devices for surgical fixation of bone fractures and joint replacement for upper and lower extremities as well as for the craniomaxillofacial region. The Group has manufacturing sites in the United States, Switzerland, Brazil and France. Medartis employs approx. 1,400 individuals across its 13 locations, with products offered in over 50 countries globally. Medartis is committed to providing surgeons and operating theatre personnel with the most innovative implants and instruments as well as best-in-class service. For more information, please visit www.medartis.com.

Your contact: Medartis Holding AG
Hochbergerstrasse 60E
CH-4057 Basel Corporate Communications
Investor contact: [e-mail]
Media contact: [e-mail]
[phone]

---

End of Media Release
View original content: EQS News

---

Language:	English
Company:	Medartis Holding AG
	Hochbergerstrasse 60E
	4057 Basel
	Switzerland
Phone:	[phone]
Fax:	[phone]
E-mail:	[e-mail]
Internet:	www.medartis.com
ISIN:	CH0386200239
Valor:	38620023
Listed:	SIX Swiss Exchange
EQS News ID:	2274032

End of News	EQS News Service

---

2274032  10.02.2026 CET/CEST